EN
.png){kind=small}
Crida Pharm had the honor of participating as a Silver Sponsor at the European College of Small Ruminant Health Management (ECSRHM) Annual Conference, a major scientific event that marked a premiere for Romania. The conference took place in Cluj-Napoca, from June 4-5, 2025, at the prestigious University of Agricultural Sciences and Veterinary Medicine (USAMV).
The organization of this conference in Romania for the first time represents a significant moment for both the local and international veterinary community. The full conference name was the European College of Small Ruminant Health Management (ECSRHM) Annual Conference, held from June 4-5, 2025, at the University of Agricultural Sciences and Veterinary Medicine (USAMV) in Cluj-Napoca, Romania. Crida Pharm's presence among the sponsors of such an event underscores a proactive approach and a contribution to the advancement of veterinary science in a region that is becoming increasingly relevant for global scientific exchanges. This involvement helps consolidate Romania's profile on the European veterinary stage and demonstrates Crida Pharm's role in this progress.
Crida Pharm held the position of Silver Sponsor at this prestigious conference, a testament to the company's substantial commitment to supporting scientific events and the veterinary community. This financial contribution is essential for ensuring the successful organization of a conference of such caliber, facilitating knowledge exchange and professional development in the field.
Crida Pharm's positioning as a Silver Sponsor, alongside Gold sponsors such as USAMV Cluj-Napoca and FMV Cluj-Napoca, and Bronze sponsors such as MSD and CEVA, is a strategic gesture recognizing key players in the veterinary pharmaceutical and academic sectors. This approach demonstrates Crida Pharm's understanding of the collaborative ecosystem necessary for industry progress and positions it as an active partner within this network. Public acknowledgment of other sponsors, especially major players like MSD and CEVA (global animal health companies), signals Crida Pharm's willingness to collaborate and recognize the collective effort required for advancing animal health. This contributes to fostering goodwill and reinforces the idea that Crida Pharm is part of a larger, interconnected industry working towards common goals.
The Crida Pharm team was actively present at the conference, participating in sessions and interacting with other attendees. This visual presence, materialized through the participation of the Crida Pharm team and the Teraciclin LA 300 INJ product banner, represents a tangible demonstration of the company's dedication to the small ruminant sector. The fact that the Crida Pharm team was physically present at a conference focused on small ruminant health, where top international experts delivered presentations, indicates active involvement beyond mere sponsorship. This participation suggests that Crida Pharm not only funds research and events but actively engages in knowledge exchange, potentially exploring new research directions, understanding emerging trends in animal diseases, and cultivating direct relationships with key opinion leaders and researchers. This approach can lead to future innovations in products or collaborations based on the latest scientific information.
The ECSRHM Conference had an eminently scientific format, bringing together renowned specialists and researchers from around the world. The event included 32 oral presentations, structured into 6 thematic sessions, 4 keynote lectures delivered by internationally recognized experts, and 23 poster presentations.
The participation of approximately 85 diplomates, residents, practitioners, and local veterinarians from 18 European countries, as well as from Australia and Canada, underscores the global relevance of the topics addressed and the international recognition of the ECSRHM event. This extensive participation contributes to enriching the scientific discourse and facilitating a broader exchange of knowledge and best practices. The geographical diversity of participants and research topics presented highlights the collaborative nature of small ruminant health research and the global effort to address challenges in this field.
The conference agenda was comprehensive, addressing essential themes for small ruminant health, such as advanced diagnostics, parasitic disease control, antimicrobial resistance management, biosecurity strategies, and innovations in animal welfare and production. These discussions are crucial for addressing current and future challenges in small ruminant health globally. The conference's focus on critical global challenges, such as antimicrobial resistance, parasite control, and biosecurity, demonstrates a proactive stance against major threats to animal and public health. Crida Pharm's support for this event signifies the company's alignment with these global health priorities, solidifying its reputation as a responsible and scientifically-oriented organization.
The conference addressed a series of vital themes for small ruminant health, contributing to the advancement of knowledge and the identification of best practices for improving animal health and welfare, with direct implications for farmers and the livestock industry in Romania and globally. Key topics included:
The conference's emphasis on "Population Medicine" and "Biosecurity," highlighted by Professor Constantin Cerbu's keynote lecture, directly addresses systemic challenges in Romanian small ruminant farming systems, characterized by "extensive management, mixed grazing, and very limited biosecurity infrastructure." Crida Pharm's support for this theme demonstrates a deep understanding that product sales alone are insufficient; a holistic approach to herd health management is necessary for lasting impact. By sponsoring a conference that directly addresses these structural weaknesses, Crida Pharm demonstrates not only its awareness of the unique challenges of the local market but also its commitment to the overall improvement of the industry. This transforms the relationship from a purely transactional one (selling products) into a partnership for developing long-term sustainable solutions for animal health in Romania.
The diverse range of subjects, including specific research on anthelmintic resistance, new diagnostic tools, and even rare pathologies (e.g., epidermolysis bullosa, various types of cancer), indicates that this conference promotes a highly specialized and forward-looking approach to small ruminant health. Crida Pharm's association with such cutting-edge discussions strengthens the company's image as being at the forefront of veterinary science, capable of adapting to and supporting advancements in a rapidly evolving field. In a competitive pharmaceutical market, alignment with leading research offers a significant advantage. By supporting discussions on emerging diagnostic technologies, resistance management, and even rare diseases, Crida Pharm positions itself as a company that anticipates future challenges and opportunities. This proactive involvement can lead to the development of next-generation products or services that address these specific and complex issues, thereby securing the business's future and solidifying its reputation as an innovative leader.
The ECSRHM Conference 2025 featured sessions and keynote lectures covering a wide array of relevant themes. For instance, Session 1, chaired by Jarosław Kaba, addressed the diagnosis and genetic diversity of SRLV infection, contributing to understanding challenges in diagnosing lentiviroses in small ruminants. Session 2, chaired by Karim Adjou, discussed pathologies, vaccinations, and antibiotic prescribing, including neonatal diseases, bacterial infections, and responsible antibiotic use. Professor Constantin Cerbu delivered a keynote lecture in Session 3, focusing on biosecurity and population medicine, essential for managing public health risks in Romanian small ruminant farming systems. Neil Sargison chaired Session 4, which explored genetic diversity and gastrointestinal nematode parasitism, contributing to the understanding and control of parasitoses, including anthelmintic resistance. Session 5, chaired by Delia Lacasta, addressed the differential diagnosis of viral oral lesions, crucial for early recognition of contagious viral diseases with oral manifestations. Finally, Session 6, chaired by Paula Menzies, presented advancements in pain management, hoof, and mastitis health, contributing to improved animal welfare and the management of common ailments.
The conference was a remarkable success, bringing together approximately 85 diplomates, residents, practitioners, and local veterinarians from 18 European countries, as well as from Australia and Canada. This extensive participation contributed to a fruitful exchange of ideas and the strengthening of professional networks.
Crida Pharm expresses its profound appreciation to the organizers, the University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca and the Faculty of Veterinary Medicine of Cluj-Napoca, for their exceptional efforts in hosting this landmark event. The company also thanks all participants for their valuable contributions to the scientific discussions.
Crida Pharm acknowledges and commends the contributions of the other sponsors – USAMV Cluj-Napoca and FMV Cluj-Napoca (Gold Sponsors), as well as MSD and CEVA (Bronze Sponsors) – whose support made this high-quality conference possible. This explicit mention of other sponsors is not merely a formality but a strategic recognition of key players in the veterinary pharmaceutical and academic sectors. This demonstrates Crida Pharm's understanding of the collaborative ecosystem necessary for industry progress and positions it as a partner within this network.
Crida Pharm's participation in and sponsorship of the ECSRHM Annual Conference 2025 reaffirms the company's dedication to animal health and scientific progress. By supporting an event of such magnitude, Crida Pharm strengthens its position as a leader and innovator in the field of small ruminant health.
Crida Pharm's sponsorship of a conference focused on small ruminant health, suggests a strategic focus on this specific animal segment. This approach indicates a potential specialization or significant market share in veterinary pharmaceuticals for small ruminants, allowing the company to more efficiently concentrate its research and development and marketing efforts. This signals to the target audience (veterinarians and farmers specializing in small ruminants) that Crida Pharm understands their specific needs and is a trusted partner in this field.
Crida Pharm remains committed to supporting initiatives that advance animal health and foster a collaborative environment for scientific progress, contributing to a more robust and innovative veterinary industry.
Place an order or contact a specialist for a free consultation on our E-Shop platform
